AngioDynamics (ANGO) Competitors $8.89 +0.31 (+3.61%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ANGO vs. ATEC, OFIX, SRDX, ARAY, RMTI, RSLS, ABT, ISRG, SYK, and BSXShould you be buying AngioDynamics stock or one of its competitors? The main competitors of AngioDynamics include Alphatec (ATEC), Orthofix Medical (OFIX), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), and Boston Scientific (BSX). These companies are all part of the "health care equipment" industry. AngioDynamics vs. Alphatec Orthofix Medical Surmodics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Stryker Boston Scientific AngioDynamics (NASDAQ:ANGO) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, community ranking, dividends, risk, analyst recommendations and institutional ownership. Which has preferable earnings and valuation, ANGO or ATEC? AngioDynamics has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAngioDynamics$292.73M1.23-$184.35M-$6.09-1.46Alphatec$572.74M2.32-$186.64M-$1.28-7.30 Does the media prefer ANGO or ATEC? In the previous week, Alphatec had 2 more articles in the media than AngioDynamics. MarketBeat recorded 4 mentions for Alphatec and 2 mentions for AngioDynamics. Alphatec's average media sentiment score of 0.80 beat AngioDynamics' score of 0.59 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alphatec 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in ANGO or ATEC? 89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 66.3% of Alphatec shares are held by institutional investors. 5.4% of AngioDynamics shares are held by insiders. Comparatively, 22.8% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, ANGO or ATEC? AngioDynamics has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Is ANGO or ATEC more profitable? Alphatec has a net margin of -31.06% compared to AngioDynamics' net margin of -83.95%. AngioDynamics' return on equity of -5.86% beat Alphatec's return on equity.Company Net Margins Return on Equity Return on Assets AngioDynamics-83.95% -5.86% -4.17% Alphatec -31.06%-541.39%-22.99% Do analysts rate ANGO or ATEC? AngioDynamics presently has a consensus price target of $12.00, suggesting a potential upside of 34.98%. Alphatec has a consensus price target of $17.11, suggesting a potential upside of 83.01%. Given Alphatec's higher probable upside, analysts plainly believe Alphatec is more favorable than AngioDynamics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AngioDynamics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Alphatec 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Does the MarketBeat Community favor ANGO or ATEC? AngioDynamics received 39 more outperform votes than Alphatec when rated by MarketBeat users. Likewise, 61.13% of users gave AngioDynamics an outperform vote while only 57.72% of users gave Alphatec an outperform vote. CompanyUnderperformOutperformAngioDynamicsOutperform Votes36861.13% Underperform Votes23438.87% AlphatecOutperform Votes32957.72% Underperform Votes24142.28% SummaryAlphatec beats AngioDynamics on 10 of the 18 factors compared between the two stocks. Ad Diversified Trading InstituteGenesis leading the smart algo revolution?I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before… Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from. Here’s why: It does all the heavy lifting for you… automatically. Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart!You’ll want to see what I’ve put on this page right here Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANGO vs. The Competition Export to ExcelMetricAngioDynamicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$361.24M$4.34B$5.12B$9.07BDividend YieldN/A41.46%4.91%4.22%P/E Ratio-1.4625.3791.3417.19Price / Sales1.2345.961,117.70116.80Price / Cash2.1243.4542.6437.86Price / Book1.737.364.794.78Net Income-$184.35M$13.64M$120.07M$225.60M7 Day Performance-1.22%-2.80%-1.90%-1.23%1 Month Performance27.91%0.56%11.45%3.37%1 Year Performance14.41%41.87%30.63%16.58% AngioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANGOAngioDynamics4.2797 of 5 stars$8.89+3.6%$12.00+35.0%+18.1%$361.24M$292.73M-1.46748ATECAlphatec3.8895 of 5 stars$9.54-0.8%$17.11+79.4%-35.5%$1.35B$572.74M-7.52700OFIXOrthofix Medical2.9566 of 5 stars$18.16+1.1%$23.00+26.7%+30.1%$693.89M$746.64M0.001,634Positive NewsSRDXSurmodics4.4895 of 5 stars$40.010.0%$50.00+25.0%+11.7%$573.34M$126.08M-49.42376Analyst ForecastPositive NewsARAYAccuray4.5748 of 5 stars$1.96+2.1%$9.00+359.2%-33.5%$197.11M$444.20M-11.29987News CoveragePositive NewsRMTIRockwell Medical4.1069 of 5 stars$2.05+0.5%$6.00+192.7%+16.2%$66.25M$98.92M-41.20300Analyst DowngradeRSLSReShape Lifesciences0.7812 of 5 stars$4.48-5.1%N/A-75.3%$3.18M$8.68M0.0050News CoveragePositive NewsGap UpABTAbbott Laboratories4.915 of 5 stars$113.26-0.1%$130.71+15.4%+6.4%$196.44B$41.22B34.46114,000Dividend IncreaseISRGIntuitive Surgical4.6827 of 5 stars$545.18+1.0%$550.28+0.9%+61.1%$194.18B$7.87B86.7513,676Analyst ForecastSYKStryker4.9675 of 5 stars$374.30-0.1%$404.35+8.0%+26.5%$142.69B$21.97B40.1852,000Analyst ForecastBSXBoston Scientific4.3394 of 5 stars$91.21+1.2%$95.52+4.7%+61.8%$134.43B$15.91B75.0248,000Analyst Forecast Related Companies and Tools Related Companies Alphatec Competitors Orthofix Medical Competitors Surmodics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Stryker Competitors Boston Scientific Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ANGO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANGO Stock Alerts